MX22020A - Procedimiento para la preparacion de nuevos acidos omega-fenil-amino-alcanoicos, substituidos en el nucleo aromatico con un radical derivado de 19-nor-esteroides y sus sales y producto obtenido. - Google Patents

Procedimiento para la preparacion de nuevos acidos omega-fenil-amino-alcanoicos, substituidos en el nucleo aromatico con un radical derivado de 19-nor-esteroides y sus sales y producto obtenido.

Info

Publication number
MX22020A
MX22020A MX2202090A MX2202090A MX22020A MX 22020 A MX22020 A MX 22020A MX 2202090 A MX2202090 A MX 2202090A MX 2202090 A MX2202090 A MX 2202090A MX 22020 A MX22020 A MX 22020A
Authority
MX
Mexico
Prior art keywords
denotes
salts
preparation
steroids
phenyl
Prior art date
Application number
MX2202090A
Other languages
English (en)
Inventor
Martine Moguilewsky
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MX22020A publication Critical patent/MX22020A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2202090A 1989-08-23 1990-08-20 Procedimiento para la preparacion de nuevos acidos omega-fenil-amino-alcanoicos, substituidos en el nucleo aromatico con un radical derivado de 19-nor-esteroides y sus sales y producto obtenido. MX22020A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911173A FR2651233B1 (fr) 1989-08-23 1989-08-23 Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.

Publications (1)

Publication Number Publication Date
MX22020A true MX22020A (es) 1993-11-01

Family

ID=9384880

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2202090A MX22020A (es) 1989-08-23 1990-08-20 Procedimiento para la preparacion de nuevos acidos omega-fenil-amino-alcanoicos, substituidos en el nucleo aromatico con un radical derivado de 19-nor-esteroides y sus sales y producto obtenido.

Country Status (19)

Country Link
US (1) US5166146A (es)
EP (1) EP0414606B1 (es)
JP (1) JP3026997B2 (es)
KR (1) KR910004655A (es)
CN (1) CN1033808C (es)
AT (1) ATE113605T1 (es)
AU (1) AU634569B2 (es)
CA (1) CA2022648A1 (es)
DE (1) DE69013815T2 (es)
DK (1) DK0414606T3 (es)
ES (1) ES2063313T3 (es)
FR (1) FR2651233B1 (es)
HU (1) HU208154B (es)
IE (1) IE65922B1 (es)
IL (1) IL95451A (es)
MX (1) MX22020A (es)
PT (1) PT95066B (es)
RU (1) RU2041236C1 (es)
ZA (1) ZA906341B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US11103514B2 (en) 2010-05-26 2021-08-31 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
JP6821582B2 (ja) 2015-03-02 2021-01-27 コーセプト セラピューティクス， インコーポレイテッド Ａｃｔｈ分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用
EP3277281B1 (en) 2015-03-30 2022-01-05 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
WO2017027851A1 (en) 2015-08-13 2017-02-16 Corcept Therapeutics, Inc. Method for differentially diagnosing acth-dependent cushing's syndrome
WO2017127448A1 (en) 2016-01-19 2017-07-27 Corcept Therapeutics, Inc. Differential diagnosis of ectopic cushing's syndrome
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
AU2018244928B2 (en) 2017-03-31 2023-10-19 Corcept Therapeutics, Inc. Glucocorticoid receptor modulators to treat cervical cancer
US11213526B2 (en) 2017-06-20 2022-01-04 Corcept Therapeutics, Inc. Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
EP4263807A2 (en) 2020-12-18 2023-10-25 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3619413C2 (de) * 1986-06-10 2000-04-06 Schering Ag 9alpha, 10alpha-Methylen-Estrene, deren Herstellung und diese enthaltende pharmazeutische Präparate
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
HU208154B (en) 1993-08-30
CN1051362A (zh) 1991-05-15
RU2041236C1 (ru) 1995-08-09
FR2651233A1 (fr) 1991-03-01
DK0414606T3 (da) 1995-02-27
FR2651233B1 (fr) 1991-12-13
PT95066A (pt) 1991-04-18
IE65922B1 (en) 1995-11-29
IL95451A (en) 1995-07-31
KR910004655A (ko) 1991-03-29
CA2022648A1 (fr) 1991-02-24
JP3026997B2 (ja) 2000-03-27
PT95066B (pt) 1997-05-28
DE69013815T2 (de) 1995-03-16
ZA906341B (en) 1991-10-30
IE903031A1 (en) 1991-02-27
ES2063313T3 (es) 1995-01-01
AU634569B2 (en) 1993-02-25
DE69013815D1 (de) 1994-12-08
EP0414606B1 (fr) 1994-11-02
HU905275D0 (en) 1991-02-28
EP0414606A3 (en) 1991-07-24
US5166146A (en) 1992-11-24
EP0414606A2 (fr) 1991-02-27
HUT54706A (en) 1991-03-28
ATE113605T1 (de) 1994-11-15
CN1033808C (zh) 1997-01-15
IL95451A0 (en) 1991-06-30
AU6118990A (en) 1991-02-28
JPH0390097A (ja) 1991-04-16

Similar Documents

Publication Publication Date Title
MX22020A (es) Procedimiento para la preparacion de nuevos acidos omega-fenil-amino-alcanoicos, substituidos en el nucleo aromatico con un radical derivado de 19-nor-esteroides y sus sales y producto obtenido.
PT93502A (pt) Processo para a preparacao de novos derivados de insulina e de composicoes farmaceuticas que os contem
ES2087990T3 (es) Poliesteramidas que contienen grupos carboxilo terminales.
MX168204B (es) Procedimiento para preparar una base solida
SE8900828L (sv) Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma
ATE8047T1 (de) (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthioessigs[ure, ihre salze und ester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
BR0008255A (pt) Composição e processo para formar emulsão estável sob cisalhamento
MY101304A (en) Pumpable highly concentrated aqueous pastes of alkali salts of (alpha) -sulfonated fatty acid alkly esters and a process for their production
SE8204918D0 (sv) Nya 3-amino-pregn-5-en-derivat, deras salter, sett for framstellning och anvendning derav som lekemedel och kompositioner innehallande dem
PT81810A (en) Process for preparing 6,7-disubstituted 1-cyclopropyl-1,4-di-hydro-oxo-1,8-naphtyridine-3-carboxylic acids
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
BR8006639A (pt) Processo para obtencao de produtos de poliadicao e respectiva aplicacao
MX163528B (es) Productos de reaccion de poli(oxialquileno)de acido succinico hidrocarbilo-substituido y/o terminados de anhidrido amina y sistemas acuosos conteniendo los mismos
DE3270717D1 (en) N-(2,2,2-trifluoroethyl)-n-alkyl-azolyloxyacetic-acid amides, their preparation and use as herbicides and intermediates for their preparation
ATE47832T1 (de) Verfahren zur herstellung von 5-(2,5dimethylphenoxy)-2,2-dimethylpentansaeure.
ES8307716A1 (es) Procedimiento para la preparacion de bis-betainas.
DE3781383D1 (de) 2,2-dimethylcyclopropancarbonsaeurederivate, die eine gesaettigte halogenierte kette an c-3 tragen, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als pestizide und sie enthaltende zusammensetzungen.
GR1002174B (en) Novel 9a-hydroxy-3-ixi-4 24(25)-sigmastadien -26-dic acid derivatives and a process for preparing same
JPS57149341A (en) Colorant for polyolefin
ES2137268T3 (es) Procedimiento para la sintesis estereoselectiva de acidos 2-sulfonilmetilpropionicos sustituidos en posicion 3 asi como productos intermedios.
ATE132873T1 (de) Amphiphile nucleosidphosphatanaloga
ES2060854T3 (es) Procedimiento para la preparacion de acido 2-mercapto-4-metil-1,3-tiazol-5-il-acetico y sus esteres.
DE3684908D1 (de) Verfahren zur herstellung von 6beta-halopenicillansaeuren und deren salzen.
DE3361150D1 (en) Steroid esters of n-(2-halogen-ethyl)-n-nitroso-carbamoyl amino acids and their peptides, and process for their preparation
ES8502985A1 (es) Procedimiento para la preparacion de alquilarilcetales alfa-sustituidos.